Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation
Pathogens · 2025
DOI: 10.3390/pathogens14090855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Ting-Ting Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Anti-Bacterial Agents. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Pharmaceutical Association.
Abstract (Originalsprache)
Pseudomonas aeruginosa, a member of the “ESKAPE” group of bacterial pathogens, exhibits biofilm-forming capacity, a key factor contributing to its resistance to conventional antibiotics and posing significant challenges in clinical treatment. To develop more effective therapeutics against such infections, identifying potential drug targets through bioinformatics analysis is essential. Consequently, we utilized data from the GEO database to investigate differentially expressed genes between planktonic and biofilm groups, and identified drug targets through the construction of a protein–protein interaction (PPI) network and the cytoHubba algorithm. Inhibitors targeting this protein were identified through molecular docking screening of the FDA-approved drug library, and their anti-biofilm activity was validated in vitro. Through bioinformatics analysis, we identified GacS as the drug target in this study for treating biofilm-related infections. Virtual screening revealed that oxidized glutathione (GSSG) and arformoterol tartrate (ARF) are both capable of tightly binding to GacS and demonstrating good stability. In vitro experiments further confirmed that both GSSG and ARF demonstrated anti-biofilm activity, particularly when combined with azithromycin (AZM) or clarithromycin (CAM), significantly enhancing the biofilm inhibition effects of these antibiotics. This combination therapy offers a new and innovative strategy to combat biofilm-associated infections, showcasing the potential of GacS inhibitors in clinical applications. In conclusion, GSSG and ARF may serve as effective GacS inhibitors, and their combination with AZM or CAM could provide a novel approach for treating biofilm-related infections, paving the way for more effective treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.
- College of Pharmacy, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Jun Xu
Förderung
- Guangdong Pharmaceutical Association
Zitieren
APA
Liang, T. T., Wen, J. Q., Chen, G. P., Wang, R., Xu, J., & Chen, W. Y. (2025). Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation. Pathogens. https://doi.org/10.3390/pathogens14090855
Vancouver
Liang TT, Wen JQ, Chen GP, Wang R, Xu J, Chen WY. Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation. Pathogens. 2025. doi:10.3390/pathogens14090855
BibTeX
@article{Liang2025,
author = {Liang, Ting-Ting and Wen, Ju-Qi and Chen, Ge-Ping and Wang, Rui and Xu, Jun and Chen, Wen-Ying},
title = {Identification and Validation of Promising Targets and Inhibitors of Biofilm Formation in Pseudomonas aeruginosa: Bioinformatics, Virtual Screening, and Biological Evaluation},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14090855}
}
EUVIMED